Triazenes and antibacterial activity;Triazenos e atividade antibacteriana

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 44, Issue 3, 2008, Pages 441-449

  Hörner, Manfredo ^a   Giglio, Vinícius Feltrin ^a   Dos Santos, Aline Joana Rolina Wohlmuth Alves ^a   Westphalen, André Bilibio ^a   Iglesias, Bernardo Almeida ^a   Martins, Paulo Roberto ^a   Do Amaral, Carlos Henrique ^a   Michelot, Tiago Mozaquatro ^a   Reetz, Luiz Gustavo Brenner ^a   Bertoncheli, Cláudia De Mello ^a   Paraginski, Gustavo Luiz ^a   Horner, Rosmari ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Broth microdilution method; Triazenes antibacterial activity

Indexed keywords

1 METHYL 3 (4 CARBOXYPHENYL)TRIAZINE 1 OXIDE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ACINETOBACTER LWOFFII; ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BORDETELLA BRONCHISEPTICA; CORYNEBACTERIUM; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROCOCCUS; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; NONHUMAN; PSEUDOMONAS AERUGINOSA; RALSTONIA PICKETTII; RHODOCOCCUS; SALMONELLA; SERRATIA MARCESCENS; SHIGELLA FLEXNERI; SHIGELLA SONNEI; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE; STRUCTURE ACTIVITY RELATION; ULTRAVIOLET SPECTROSCOPY;

EID: 55849112991     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322008000300014     Document Type: Article

References (34)

1. BRASIL. Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Manual de microbiologia clínica para o controle de infecção em serviços de saúde: Brasília: ANVISA, 2004. Módulos I, p.65; II, p.37; III, p.43; IV, p.64 e V, p.93.
2. CARSON, C., NARBER, K. G. Role of fluorquinolones in treatment of serious bacterial urinary tract infections. Drugs, v.64, p.1359-1373, 2004.
3. CARVALHO, E.; FRANCISCO, A. P.; ILEY, J.; ROSA, E. Triazene drug metabolites. Part 17: Synthesis and plasma hydrolysis of acyloxymethyl carbamate derivatives of antitumour triazenes. Bioorg. Med. Chem., v.8, p.1719-1725, 2000.
4. CLINICAL AND LABORATORY STANDARDS INSTITUTE. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard. 6.ed. Wayne: NCCLS, 2003. p.53. (NCCLS document M7-A6).
5. COUDRON, P. E.; HANSON, N. D.; CLIMO, M. W. Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-ediated FOX-5 and ACT-1 AmpC Beta-Lactamases. J. Clin. Microbiol., v.41, p.772-777, 2003.
6. GIGLIO, V. F. Síntese e cristaloquímica de complexos de Hg(II) e Ni(II) com o ligante 3-(2-fluorofenil)-1-(4-acetilfenil)triazenido e atividade biológica de triazenos livres. Santa Maria, 2006. 135 f. [Dissertação de Mestrado. Universidade Federal de Santa Maria].
7. GOSWAMI, A. K.; PUROHIT, D. N. Synthesis and antimicrobial activities of some hydroxytriazenes: a new class o biologically active compounds. Anal. Sci., v.17, p.1789-1791, 2001.
8. HÖRNER, M.; BRANCHER, A.L.; SILVA, A.; BORDINHÃO, J.; MOESSMER, C. M. 3-(4-Acetylphenyl)-1-(4-nitrophenyl)-triazene. Acta Crystallogr., Sect. C: Cryst. Struct. Commun, v.C60, p.303-304, 2004.
9. HÖRNER, M.; BRESOLIN, L.; BORDINHÃO, J.; HARTMANN, E.; STRÄHLE, J. 1,3-Bis(4-nitrophenyl)triazene. Acta Crystallogr., Sect. C: Cryst. Struct. Commun, v.59, p.426-427, 2003.
10. 4-arene π-interactions and non classical C-H⋯O bonding: Synthesis and X-Ray characterization of a bis diaryl symmetric-substituted triazenide complex polymer of Hg(II). Z. Anorg. Allg. Chem., v.632, p.615-618, 2006a.
11. HÖRNER, M.; OLIVEIRA, G. M.; GIGLIO, V. F.; VISENTIN, L. C.; BROCH, F.; BECK, J. Inorg. Chim. Acta, v.359, p.2309, 2006b.
12. HÖRNER, R. Estudo de compostos capazes de clivar o DNA. Florianópolis, 2003. Número de páginas? [Tese de Doutorado. Universidade Federal de Santa Catarina]. p.238.
13. 3,O]dipyridinenickel(II). Acta Crystallogr., Sect. C, v.C58, p.m586-m587, 2002.
14. JONES, R. N.; PFALLER, M. A. Antimicrobial activity against strains of Escherichia coli and Klebsiella sp. with resistance phenotypes consistent with an extended-spectrum β-lactamase in Europe. Clin. Microbiol. Infect., v.9, p.708-712, 2003.
15. JACKSON, L. A.; HILSDON, R.; FARLEY, M. M.; HARRISON, L. H.; REINGOLD, A. L.; PLIKAYTIS, B. D.; WENGER, J. D.; SCHUCHAT, A. Risk factors for group B streptococcal disease in adults. Ann. Intern. Med., v.123, p.415-420, 1993.
16. 2-lactam antibiotics. Scand. J. Infect. Dis., v.78, p.7-16, 1991.
17. MURRAY, P. R.; BARON, E. J.; PFALLER, M. A.; TENOVER, F. C.; YOLKEN, R. H. M. Manual of clinical microbiology. 8. ed. Washington: ASM Press, 2003. p. 2113.
18. MURRAY, R. P.; ROSENTHAL, K. S.; KOBAYASHI, G. S.; PFALLER, M. A. Microbiologia médica. 4 ed. Rio de Janeiro: Guanabara Koogan, 2004. p. 776.
19. PAGANI, L.: DELL'AMICO, E.; MIGLIAVACCA, R.; D'ANDREA, M. M.; GIACOBONE, E.; AMICOSANTE, G.; ROMERO, E.; ROSOLINI, G. M. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J. Clin. Microbiol., v.41, p.4264-4269, 2003.
20. PARAGINSKI, G. L.; REETZ, L. G. B.; MICHELOT, T. M.; DOMINGUES, V. O.; BERTONCHELI, C. M.; MARASCHIN, M. M.; VISENTIN, L. C.; SILVA, A.; GIGLIO, V. F. WETSPHALEN, A. B.; AMARAL, C. H. O.; HÖRNER, M.; HÖRNER, R. Avaliação da atividade de clivagem do DNA plasmidial por cinco compostos triazenos inéditos. In: CONGRESSO BRASILEIRO DE ANÁLISES CLÍNICAS, 33.; CONGRESSO BRASILEIRO DE CITOLOGIA CLÍNICA, 6., 2006, Curitiba. Resumos. Rio de Janeiro: Sociedade Brasileira de Análises Clinicas, 2006. p.90B, res. n.363.
21. PARODI, S.; LECHNER, A.; OSIH, R.; VESPA, P.; PEGUES, D. Nosocomial Enterobacter meningitis: risk factors, management, and treatment outcomes. Clin. Infect. Dis., v.15, p.159-166, 2003.
22. PEORI, M. B.; VAUGHAN, K.; HOOPER, D.L. Synthesis and Characterization of Novel Bis-Triazenes: 3,8-Di[2-aryl-1-azenyl]-1,3,6,8-tetraazabicyclo[4.4.1] undecanes and 1,3-Di-2-[(4-methoxyphenyl)-1-diazenyl]imidazolidine. The reaction of diazonium ions with ethylenediamine/formaldehyde mixtures. J. Org. Chem., v.63, p.7437-7444, 1998.
23. 2-lactamase de espectro ampliado. J. Bras. Patol. Med. Labor., v.39, p.301-308, 2005.
24. PILCH, D. S.; KIROLOS, M. A.; LIU, X.; PLUM, G. E.; BRESLAUER, K. J. Berenil [1,3-bis-(4-amidinophenyl)triazene] binding to DNA duplexes and a RNA duplex: evidence for both intercalative and minor groove binding properties. Biochemistry, v.34, p.9962-9976, 1995.
25. SADER, H. S.; GALES, A. C.; PFALLER, M. A.; MENDES, R. E.; ZOCCOLI, C.; BARTH, A.; JONES, R. N. Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY antimicrobial surveillance program. Braz. J. Clin. Microbiol., v.5, p.200-214, 2001.
26. SANADA, M.; TAKAGI, Y.; SEKIGUCHI, M. Killing and mutagenic actions of dacarbazine, a chemotherapeutic alkylating agent, on human and mouse cells: effects of Mgmt and Mlh1 mutations. DNA repair, v.3, p.413-420, 2004.
27. SANDERS, W. E.; SANDERS, C. C. Enterobacter sp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev., v.10, p.220-241, 1997.
28. SANTOS, A. J. R. W. A. Síntese, estruturas de triazeno 1-óxido e complexo de K+, e avaliação da atividade biológica de 1-metiltriazeno 1-óxido e 1,3-bis(aril)triazenos. Santa Maria, 2005. p.53 [Dissertação de Mestrado. Universidade Federal de Santa Maria].
29. SCHUCHAT, A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev., v.11, p.497-513, 1998.
30. SHEALY, Y. F.; KRAUTH; C. A.; PITTILLD, R. F.; HUNT, D. E. A new antifungal and antibacterial agent, methyl 5(or 4)-(3,3-dimethyl-1-triazeno) imidazole-4(or 5)-carboxylate. J. Pharm. Sci., v.15, p.147-148, 1966.
31. TAKAHASHI, H.; KRAMER, M. H.; YASUI, Y.; FUJII, H.; NAKASE, K.; IKEDA, K.; IMAI, T.; OKAZAWA, A.; TANAKA, T.; OHYAMA, T.; OKABE, N. Nosocomial Serratia marcescens outbreak in Osaka, Japan, from 1999 to 2000. Infect. Control. Hosp. Epidemiol., v.25, p.156-161, 2004.
32. TRAUTNER, B. W.; DAUROWCH, R. O. Role of biofilm in catheter-associated urinary tract infection. Amer. J. Infect. Control, v.32, p.177-183, 2004.
33. ZAR, H. J.; COTTON, M. F. Nosocomial pneumonia in pediatric patients: practical problems and rational solutions. Ped. Drugs, v.4, p.73-83, 2002.
34. ZHAO, S.; XIA, X,; XIANGWEN, K.; LIU, T. Highly sensitive colour-reaction of nickel with a new chromogenic reagent benzothiaxolyldiazoaminoazobenzene and its application. Talanta, v.45, p.13-17, 1997.